MX2007012507A - Profarmacos de anfetamina resistentes al abuso. - Google Patents
Profarmacos de anfetamina resistentes al abuso.Info
- Publication number
- MX2007012507A MX2007012507A MX2007012507A MX2007012507A MX2007012507A MX 2007012507 A MX2007012507 A MX 2007012507A MX 2007012507 A MX2007012507 A MX 2007012507A MX 2007012507 A MX2007012507 A MX 2007012507A MX 2007012507 A MX2007012507 A MX 2007012507A
- Authority
- MX
- Mexico
- Prior art keywords
- abuse
- amphetamine
- compositions
- compounds
- bioavailability
- Prior art date
Links
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 title abstract 5
- 229940025084 amphetamine Drugs 0.000 title abstract 5
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 201000003631 narcolepsy Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66938505P | 2005-04-08 | 2005-04-08 | |
| US66938605P | 2005-04-08 | 2005-04-08 | |
| US68117005P | 2005-05-16 | 2005-05-16 | |
| US75654806P | 2006-01-06 | 2006-01-06 | |
| US75995806P | 2006-01-19 | 2006-01-19 | |
| PCT/US2006/013221 WO2006121552A2 (en) | 2005-04-08 | 2006-04-10 | Abuse-resistant amphetamine prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007012507A true MX2007012507A (es) | 2008-03-11 |
Family
ID=37397039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007012507A MX2007012507A (es) | 2005-04-08 | 2006-04-10 | Profarmacos de anfetamina resistentes al abuso. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1865980A4 (enExample) |
| JP (1) | JP2008535860A (enExample) |
| BR (1) | BRPI0612440A2 (enExample) |
| CA (1) | CA2603873A1 (enExample) |
| MX (1) | MX2007012507A (enExample) |
| WO (1) | WO2006121552A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8318813B2 (en) | 2007-09-13 | 2012-11-27 | Lcs Group, Llc | Method of treating binge eating disorder |
| WO2010042120A1 (en) | 2008-10-09 | 2010-04-15 | Archimica, Inc. | Process for the synthesis of amphetamine derivatives |
| GB201002612D0 (en) * | 2010-02-16 | 2010-03-31 | Jagotec Ag | Improvements in or relating to organic compounds |
| US20140073589A1 (en) * | 2012-06-27 | 2014-03-13 | Shire Ag | Amphetamine Prodrugs |
| US11879019B2 (en) | 2016-12-19 | 2024-01-23 | The Regents Of The University Of California | Dual-enzyme responsive peptides |
| WO2018118903A1 (en) | 2016-12-19 | 2018-06-28 | The Regents Of The University Of California | Noncrushable pill formulatiions |
| ES2806995T3 (es) | 2017-09-20 | 2021-02-19 | Sandoz Ag | Sales cristalinas de un profármaco de dextroanfetamina |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| JP2022529353A (ja) | 2019-04-17 | 2022-06-21 | コンパス パスファインダー リミテッド | 神経認知障害、慢性疼痛を治療し、炎症を低減させる方法 |
| HUE059869T2 (hu) * | 2019-12-30 | 2023-01-28 | Labomed Pharmaceutical Company S A | Lizdexamfetamin-sókat tartalmazó orális oldatok |
| JP2023549405A (ja) | 2020-11-18 | 2023-11-24 | マインド メディシン， インコーポレイテッド | 心理療法を補助するためのｍｄｍａプロドラッグ |
| US20250064759A1 (en) | 2021-12-16 | 2025-02-27 | Labomed Pharmaceutical Company S.A. | Container comprising a lisdexamfetamine containing oral solution |
| EP4561528A1 (en) | 2022-07-29 | 2025-06-04 | Labomed Pharmaceutical Company S.A. | Lisdexamfetamine containing oral solution |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3878187A (en) * | 1972-09-11 | 1975-04-15 | Syva Co | Polypeptide derivatives of amphetamine and analogs for immunoassays |
| US6384020B1 (en) * | 1999-07-14 | 2002-05-07 | Shire Laboratories, Inc. | Rapid immediate release oral dosage form |
| IL158959A (en) * | 2001-05-25 | 2010-06-30 | Cephalon Inc | Solid pharmaceutical formulations comprising modafinil |
| US7105486B2 (en) * | 2002-02-22 | 2006-09-12 | New River Pharmaceuticals Inc. | Abuse-resistant amphetamine compounds |
| AU2004277400B2 (en) * | 2003-09-30 | 2009-01-22 | Shire Llc | Pharmaceutical compositions for prevention of overdose or abuse |
-
2006
- 2006-04-10 WO PCT/US2006/013221 patent/WO2006121552A2/en not_active Ceased
- 2006-04-10 EP EP06769808A patent/EP1865980A4/en not_active Withdrawn
- 2006-04-10 JP JP2008505617A patent/JP2008535860A/ja active Pending
- 2006-04-10 MX MX2007012507A patent/MX2007012507A/es unknown
- 2006-04-10 BR BRPI0612440-2A patent/BRPI0612440A2/pt not_active Application Discontinuation
- 2006-04-10 CA CA002603873A patent/CA2603873A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2603873A1 (en) | 2006-11-16 |
| WO2006121552A3 (en) | 2007-07-05 |
| WO2006121552A2 (en) | 2006-11-16 |
| WO2006121552A9 (en) | 2007-03-08 |
| JP2008535860A (ja) | 2008-09-04 |
| BRPI0612440A2 (pt) | 2010-11-23 |
| EP1865980A2 (en) | 2007-12-19 |
| EP1865980A4 (en) | 2009-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE2020C543I2 (enExample) | ||
| MX2007012507A (es) | Profarmacos de anfetamina resistentes al abuso. | |
| WO2009036092A9 (en) | Mitochondria-targeted anti-tumour agents | |
| MX2010001371A (es) | Carboxamidas opioides cuaternarias. | |
| MX2009004108A (es) | Compuestos de tetrahidropirrolopiracina sustituidos teniendo afinidad al canal kcnq2/3 k+ y su uso en farmacos. | |
| PL1853602T3 (pl) | Związki chemiczne | |
| PT1853588E (pt) | Compostos químicos | |
| MY153243A (en) | Compound for inhibiting mitotic progression | |
| UA92670C2 (ru) | Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе | |
| MX2010005649A (es) | Compuestos novedosos como ligandos del receptor canabinoide y sus usos. | |
| TW200942535A (en) | Novel compounds as cannabinoid receptor ligands | |
| IL183383A0 (en) | Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 | |
| TW200726747A (en) | Chemical compounds | |
| PL2313386T3 (pl) | Drogi syntezy do 2(S),4(S),5(S),7(S)-2,7-dialkilo-4-hydroksy-5-amino-8-arylo-oktanoiloamidów | |
| WO2008020306A3 (en) | Isoindole derivatives | |
| MY146084A (en) | Benzyl amines, a process for their production and their use as anti-inflammatory agents | |
| TW200730493A (en) | Chemical compounds | |
| EP1757558A4 (en) | Method for preparing carbon nanostructure | |
| WO2008059130A9 (fr) | Thionucléosides et applications pharmaceutiques | |
| WO2005012271A3 (en) | Process for the synthesis of biaryl oxazolidinones | |
| EA200701687A1 (ru) | Гидрохлорид аморфного лерканидипина | |
| WO2006020348A3 (en) | Polymorphs of atomoxetine hydrochloride | |
| MX2007010400A (es) | Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo. | |
| WO2006089406A8 (en) | Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents | |
| GB0520554D0 (en) | Improvements in induced heteroduplex generators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assignment |